Carronade Capital Management, LP Bausch Health Companies Inc. Transaction History
Carronade Capital Management, LP
- $1.78 Billion
- Q2 2024
A detailed history of Carronade Capital Management, LP transactions in Bausch Health Companies Inc. stock. As of the latest transaction made, Carronade Capital Management, LP holds 62,841 shares of BHC stock, worth $608,929. This represents 0.02% of its overall portfolio holdings.
Number of Shares
62,841
Previous 400,000
84.29%
Holding current value
$608,929
Previous $4.24 Million
89.68%
% of portfolio
0.02%
Previous 0.29%
Shares
2 transactions
Others Institutions Holding BHC
# of Institutions
265Shares Held
279MCall Options Held
5.68MPut Options Held
17.4M-
Icahn Carl C Sunny Isles Beach, FL34.7MShares$336 Million2.24% of portfolio
-
John Paulson Paulson & Co. Inc. | New York, Ny26.4MShares$256 Million14.13% of portfolio
-
Goldentree Asset Management LP New York, NY22.4MShares$217 Million15.5% of portfolio
-
Nomura Holdings Inc Tokyo, M019.4MShares$188 Million0.27% of portfolio
-
National Bank Of Canada15.7MShares$152 Million0.17% of portfolio
About Bausch Health Companies Inc.
- Ticker BHC
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 361,728,000
- Market Cap $3.51B
- Description
- Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...